Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PK Interactions of Digoxin, Furosemide, Metformin, and Rosuvastatin Cocktail
NCT02854527Phase 1Completed
- Sponsor
- Boehringer Ingelheim
- Start
- Aug 2016
- Primary completion
- Nov 2016
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of digoxin, furosemide, metformin and rosuvastatin (5 arms), sponsored by Boehringer Ingelheim. Primary endpoints: Area Under the Curve From 0 to Last Quantifiable Data Point and Maximum Concentration. Started Aug 2016; status: completed.
02
Drugs
digoxinfurosemidemetforminrosuvastatin
Beyond the preview
Go deeper on NCT02854527.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02854527.